G

Gilead Sciences

13587 employees

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

Investor insights

Sectors invested in

Biotechnology26
Health Care23
Therapeutics15
Medical12
Pharmaceutical8
Clinical Trials8
Life Science5
Genetics4
Medical Device4
Manufacturing3
Non Profit3
Biopharma3
Cell Therapy3
Immuno-oncology3
Infectious disease3
Oncology3
Kidney Disease2
Rare Subsets of Diabetic Nephropathy2
Focal Segmental Glomerulosclerosis (FSGS)2
Precision Medicine2

Funding rounds participated in

$68M sweet spot round size

Most of their 40 investments are in rounds between $35M and $168M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Manufacturing
Pharmaceutical
Biopharma

Date founded

1987

Investments made

T

Tentarix Biotherapeutics, Inc. raised $35M on September 6, 2023

Investors: Versant Ventures, Amplitude Ventures, Samsara BioCapital and Gilead Sciences

T

Tentarix Biotherapeutics, Inc. raised undisclosed on August 15, 2023

Investors: Gilead Sciences

H

HEROES Inc.: Helping Everyone Receive Ongoing and Effective Support raised undisclosed on March 22, 2023

Investors: Gilead Sciences

P

PCAF (Pierce County AIDS Foundation) raised undisclosed on March 22, 2023

Investors: Gilead Sciences

C

Central Illinois FRIENDS raised undisclosed on March 22, 2023

Investors: Gilead Sciences

U

Undisclosed raised undisclosed on March 22, 2023

Investors: Gilead Sciences

U

Undisclosed raised undisclosed on March 22, 2023

Investors: Gilead Sciences

-

- raised undisclosed on March 22, 2023

Investors: Gilead Sciences

U

Undisclosed raised undisclosed on March 6, 2023

Investors: Gilead Sciences

N

Nueva Vida, Support Network for Latinas with Cancer raised undisclosed on February 1, 2023

Investors: Gilead Sciences

Funding rounds raised

G

Gilead Sciences raised undisclosed on January 1, 1988

Investors: Venrock

FAQ